scholarly journals Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 5592-5592 ◽  
Author(s):  
Andrea P. Myers ◽  
Virginia L. Filiaci ◽  
Yuping Zhang ◽  
Michael Pearl ◽  
Kian Behbakht ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Phase Ii ◽  
Mutational Analysis ◽  
Phase Ii Study ◽  
Gynecologic Oncology ◽  
Megestrol Acetate ◽  
Gynecologic Oncology Group ◽  
Oncology Group ◽  
Oncology Group Study

Phase II Study of Ifosfamide and Mesna in Nonsquamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study

1993 ◽  
Vol 49 (1) ◽  
pp. 48-50 ◽  
Author(s):  
Gregory P. Sutton ◽  
John A. Blessing ◽  
Philip J. DiSaia ◽  
William P. McGuire
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Oncology Group ◽  
Oncology Group Study

Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study

2006 ◽  
Vol 103 (2) ◽  
pp. 523-526 ◽  
Author(s):  
Paula M. Fracasso ◽  
John A. Blessing ◽  
Kelly L. Molpus ◽  
Lisa M. Adler ◽  
Joel I. Sorosky ◽  
...  
Keyword(s):  
Endometrial Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Second Line ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document